Quinidine sulfate

CAS No. 6591-63-5

Quinidine sulfate( Quinidine sulfate dihydrate | Chinidin Sodium | Pitayine Sodium | β-quinine Sodium )

Catalog No. M21195 CAS No. 6591-63-5

Quinidine sulfate dihydrate is a potent and selective cytochrome P450db inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 56 In Stock
5MG 35 In Stock
10MG 48 In Stock
25MG 67 In Stock
50MG 94 In Stock
100MG 142 In Stock
200MG 214 In Stock
500MG 359 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Quinidine sulfate
  • Note
    Research use only, not for human use.
  • Brief Description
    Quinidine sulfate dihydrate is a potent and selective cytochrome P450db inhibitor.
  • Description
    Quinidine sulfate dihydrate is a potent and selective cytochrome P450db inhibitor.(In Vitro):Quinidine hydrochloride monohydrate blocks WT mSlo3 (KCa5.1) channels with an IC50 of 19.9±1.41 μM and Hill slope of 1.15±0.15 (n=7). Again, the potency of inhibition by Quinidine hydrochloride monohydrate is higher for F304Y mSlo3 (IC50 of 2.42±0.60 μM, n=9, P<0.005; Hill slope of 0.98±0.12), but lower with R196Q mSlo3 (IC50 of 38.4±6.77 μM, n=5, P<0.001; Hill slope of 1.05±0.16). The inhibition of F304Y mSlo3 by Quinidine hydrochloride monohydrate is observed to have some time dependence.(In Vivo):Direct application of Quinidine hydrochloride monohydrate on the sciatic nerve produces a dose-related decrease in amplitude at ascending somato-sensory evoked potential (SSEP) and descending compound muscle action potentials (CMAP) when comparing baseline with other time points, or when comparing the experimental left limb to the right contra-lateral glucose-treated limb. The latencies of SSEPs and CMAP potentials after Quinidine hydrochloride monohydrate applications are increased compare to baseline and the contralateral side.
  • In Vitro
    Quinidine sulfate dihydrate shows cytotoxicity against MES-SA cells, and induces apoptosis.
  • In Vivo
    Quinidine sulfate dihydrate shows effects on the PTZ-induced seizure threshold. Animal Model:Male mice of the NMRI strain (age 5-6 weeks and weight 25-30 g)Dosage:10, 20, and 30 mg/kg Administration: Intraperitoneal injection; 10, 20, and 30 mg/kg; once Result:Increased the threshold dose for the onset to tonic hind limb extension at a dose of 30 mg/kg, compared to the saline-treated control group (p<0.05).
  • Synonyms
    Quinidine sulfate dihydrate | Chinidin Sodium | Pitayine Sodium | β-quinine Sodium
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    P450
  • Recptor
    CYP450
  • Research Area
    Cardiovascular Disease
  • Indication
    Arrhythmia

Chemical Information

  • CAS Number
    6591-63-5
  • Formula Weight
    782.9
  • Molecular Formula
    C40H54N4O10S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:100 mg/mL (154.12 mM)Ethanol:100 mg/mL (154.12 mM)H2O:9 mg/mL (13.87 mM)
  • SMILES
    C=CC1CN2CCC1CC2C(O)c1ccnc2ccc(OC)cc12.C=CC1CN2CCC1CC2C(O)c1ccnc2ccc(OC)cc12.O.O.O=S(=O)(O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Tsuruo T Iida H Kitatani Y et al. Effects of Quinidine and Related Compounds on Cytotoxicity and Cellular Accumulation of Vincristine and Adriamycin in Drugresistant Tumor Cells[J]. Cancer Research 1984 44(10):4303-4307.
molnova catalog
related products
  • EN3356

    EN3356 is an orally available and selective inhibitor of steroidal 17-alpha-hydroxylase/C17,20 cleavage enzyme (CYP17A1 or CYP17), a non-steroidal cleavage enzyme-selective compound with potential anti-androgenic and anti-tumor activity.

  • LY 43578

    LY 43578 is an orally active aromatase inhibitor. LY43578 could inhibit O-demethylation of P-450-dependent p-nitroanisole and N-demethylation of ethylmorphine (IC50 of 0.3 and 5 μm, respectively) in rat liver microsomes.

  • Cholesterol 24-hydro...

    Cholesterol 24-hydroxylase-IN-1 is an orally active, selective, and potent inhibitor of cholesterol 24-hydroxylase (CH24H or CYP46A1) that crosses the blood-brain barrier.